利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

209 条记录 (耗时 0.035 秒)

    Systems and methods for monitoring gastrointestinal system
    1.
    发明授权
    Systems and methods for monitoring gastrointestinal system 有权
    用于监测胃肠系统的系统和方法

    公开(公告)号：US07141016B2

    公开(公告)日：2006-11-28

    申请号：US10423594

    申请日：2003-04-25

    申请人： Michael Lykke ,  Michael Madsen ,  Martin T. Gerber ,  Warren L. Starkebaum

    发明人： Michael Lykke ,  Michael Madsen ,  Martin T. Gerber ,  Warren L. Starkebaum

    IPC分类号： A61B5/00

    CPC分类号： A61B5/14539 ,  A61B5/062 ,  A61B5/07 ,  A61B5/14532 ,  A61B5/4238

    摘要： In general, the invention is directed to systems and methods for monitoring the gastrointestinal system of a patient. In one embodiment, the invention includes techniques for monitoring the emptying of the patient's stomach. The techniques may employ glucose monitoring, pH monitoring with a consumable sensor, of monitoring the position of a consumable sensor as it exits the stomach. Consumable sensors may be employed to sense conditions, such as temperature or bile concentration, in other segments of the gastrointestinal system. The invention also includes systems for tracking the position of one or more consumable sensors as the sensors transit the gastrointestinal system, and monitoring the conditions sensed by the sensors.

    摘要翻译： 通常，本发明涉及用于监测患者的胃肠系统的系统和方法。 在一个实施例中，本发明包括用于监测患者胃排空的技术。 这些技术可以采用葡萄糖监测，用可消耗传感器进行pH监测，监测消耗型传感器在离开胃时的位置。 可以使用消耗性传感器来检测胃肠系统的其它部分中的条件，例如温度或胆汁浓度。 本发明还包括用于跟踪一个或多个消耗性传感器的位置的系统，因为传感器传送胃肠系统，并监测传感器感测到的状况。

    Implantable devices and methods for treating urinary incontinence
    2.
    发明授权
    Implantable devices and methods for treating urinary incontinence 有权
    用于治疗尿失禁的植入式装置和方法

    公开(公告)号：US07585271B2

    公开(公告)日：2009-09-08

    申请号：US10698131

    申请日：2003-11-01

    申请人： Martin T. Gerber ,  Warren L. Starkebaum ,  John M. Swoyer

    发明人： Martin T. Gerber ,  Warren L. Starkebaum ,  John M. Swoyer

    IPC分类号： A61F2/02

    CPC分类号： A61B17/00234 ,  A61B17/06109 ,  A61B17/3478 ,  A61B90/39 ,  A61B2017/00805 ,  A61B2017/00898 ,  A61B2017/306 ,  A61F2/0036 ,  A61L31/145

    摘要： In general, the invention is directed to treatment of urinary incontinence by the implantation of one or more bulking prostheses proximate to a urethral sphincter. These bulking prostheses, which may include biocompatible hydrogel, are implanted into the tissue outside the urethra, proximate to a urethral sphincter. When implanted, the bulking prostheses are in a miniature state. Upon introduction into the body, the devices enter an enlarged state. In their enlarged state, the bulking prostheses supply extra bulk to the tissues proximate to the external urethral sphincter. With the extra bulk, the patient can exercise voluntary control over the external urethral sphincter to close or maintain closure of the urethra and maintain urinary continence.

    摘要翻译： 通常，本发明涉及通过植入靠近尿道括约肌的一个或多个膨胀假体来治疗尿失禁。 这些可能包括生物相容性水凝胶的膨胀假体植入尿道外侧的组织中，靠近尿道括约肌。 当植入时，膨胀假体处于微型状态。 引入身体后，设备进入放大状态。 在扩大的状态下，膨胀假体对靠近外部尿道括约肌的组织提供额外的体积。 随着额外的体积，患者可以对外部尿道括约肌进行自愿控制，以关闭或保持尿道闭合并维持尿路。

    Implantable devices and methods for treating fecal incontinence
    3.
    发明授权
    Implantable devices and methods for treating fecal incontinence 有权
    可植入装置和治疗大便失禁的方法

    公开(公告)号：US07381180B2

    公开(公告)日：2008-06-03

    申请号：US10698216

    申请日：2003-10-31

    申请人： Martin T. Gerber ,  Warren L. Starkebaum ,  John M. Swoyer

    发明人： Martin T. Gerber ,  Warren L. Starkebaum ,  John M. Swoyer

    IPC分类号： A61F2/02

    CPC分类号： A61F2/0036 ,  A61L31/145

    摘要： In general, the invention is directed to treatment of fecal incontinence by the implantation of one or more bulking prostheses proximate to an anal sphincter. These bulking prostheses, which may include biocompatible hydrogel, are inserted into the tissue near the anus through a small opening in the mucosa. When inserted, the bulking prostheses are in a miniature state. Upon introduction into the body, the devices enter an enlarged state. In their enlarged state, the bulking prostheses supply extra bulk to the tissues proximate to the anal sphincters. With the extra bulk, the patient can exercise voluntary control over the external sphincter to close the anus and maintain fecal continence.

    摘要翻译： 通常，本发明涉及通过植入靠近肛门括约肌的一个或多个膨胀假体来治疗大便失禁。 这些膨胀假体可以包括生物相容的水凝胶，通过粘膜中的小开口插入到肛门附近的组织中。 当插入时，膨胀假体处于微型状态。 引入身体后，设备进入放大状态。 在扩大的状态下，膨胀假体向靠近肛门括约肌的组织提供额外的体积。 随着额外的体积，患者可以对外括约肌进行自愿控制以闭合肛门并维持粪便的排列。

    Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves
    5.
    发明授权
    Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves 有权
    用于通过电刺激骶神经和/或阴部神经来治疗盆底疾病的方法，系统和装置

    公开(公告)号：US09272140B2

    公开(公告)日：2016-03-01

    申请号：US12059243

    申请日：2008-03-31

    申请人： Martin T. Gerber

    发明人： Martin T. Gerber

    IPC分类号： A61N1/36 ,  A61N1/05

    CPC分类号： A61N1/36007 ,  A61N1/0507 ,  A61N1/0521 ,  A61N1/0551 ,  A61N1/36071 ,  A61N1/36107

    摘要： Described are implantable devices and methods for treating various disorders of the pelvic floor by means of electrical stimulation of tissue volumes at two or more locations adjacent sacral nerves or portions thereof, and/or pudendal nerves or portions thereof. Two or more electrical stimulation regimes are applied on a continuous, alternating, intermittent or other basis to the respective tissue volumes in an amount and manner effective to treat a number of disorders, including, but not limited to, urinary and/or fecal voiding dysfunctions such as constipation, incontinence disorders such as urge frequency and urinary retention disorders, sexual dysfunctions such as orgasmic and erectile dysfunction, pelvic pain, prostatitis, prostatalgia and prostatodynia.

    摘要翻译： 描述了通过在邻近骶神经或其部分的两个或更多个位置和/或阴部神经或其部分上的组织体积的电刺激来治疗盆底的各种疾病的可植入装置和方法。 两种或更多种电刺激方案以连续，交替，间歇或其他方式以相应的组织体积施用，其数量和方式有效地治疗许多障碍，包括但不限于尿和/或粪便排泄功能障碍 例如便秘，失禁症例如呼吸频率和尿潴留障碍，性功能障碍如高血压和勃起功能障碍，盆腔疼痛，前列腺炎，前列腺痛和前列腺痛。

    Sorbent cartridge configurations for improved dialysate regeneration
    6.
    发明授权
    Sorbent cartridge configurations for improved dialysate regeneration 有权
    吸附剂盒配置，用于改善透析液再生

    公开(公告)号：US09144640B2

    公开(公告)日：2015-09-29

    申请号：US13836973

    申请日：2013-03-15

    申请人： Bryant J. Pudil ,  Thomas E. Meyer ,  David B. Lura ,  Martin T. Gerber

    发明人： Bryant J. Pudil ,  Thomas E. Meyer ,  David B. Lura ,  Martin T. Gerber

    IPC分类号： A61M1/16

    CPC分类号： A61M1/1656 ,  A61M1/1654 ,  A61M1/1668 ,  A61M1/167 ,  A61M1/1696 ,  A61M1/287 ,  A61M1/3486 ,  A61M2205/02 ,  B01D15/08

    摘要： A regeneration system that has a first regeneration module containing a first chosen regenerative substance; a second regeneration module containing the first chosen regenerative substance; and a first mixing chamber. A first outlet stream of a fluid sequentially exits the first mixing chamber, flows through the first regeneration module in fluid communication with the first chosen regenerative substance and returns to the first mixing chamber, and a second outlet stream of the fluid sequentially exits the first mixing chamber and flows through the second regeneration module in fluid communication with the first chosen regenerative substance.

    摘要翻译： 一种再生系统，其具有包含第一选择再生物质的第一再生模块; 包含第一选择再生物质的第二再生模块; 和第一混合室。 流体的第一出口流顺序地离开第一混合室，流过第一再生模块与第一选择的再生物质流体连通并返回到第一混合室，并且流体的第二出口流依次离开第一混合 并且与第一选择的再生物质流体连通地流过第二再生模块。

    SORBENT CARTRIDGE CONFIGURATIONS FOR IMPROVED DIALYSATE REGENERATION
    7.
    发明申请
    SORBENT CARTRIDGE CONFIGURATIONS FOR IMPROVED DIALYSATE REGENERATION 有权
    用于改进的透析再生的SORBENT CARTRIDGE配置

    公开(公告)号：US20140217028A1

    公开(公告)日：2014-08-07

    申请号：US13836973

    申请日：2013-03-15

    申请人： Bryant J. Pudil ,  Thomas E. Meyer ,  David B. Lura ,  Martin T. Gerber

    发明人： Bryant J. Pudil ,  Thomas E. Meyer ,  David B. Lura ,  Martin T. Gerber

    IPC分类号： A61M1/16

    CPC分类号： A61M1/1656 ,  A61M1/1654 ,  A61M1/1668 ,  A61M1/167 ,  A61M1/1696 ,  A61M1/287 ,  A61M1/3486 ,  A61M2205/02 ,  B01D15/08

    摘要： A regeneration system that has a first regeneration module containing a first chosen regenerative substance; a second regeneration module containing the first chosen regenerative substance; and a first mixing chamber. A first outlet stream of a fluid sequentially exits the first mixing chamber, flows through the first regeneration module in fluid communication with the first chosen regenerative substance and returns to the first mixing chamber, and a second outlet stream of the fluid sequentially exits the first mixing chamber and flows through the second regeneration module in fluid communication with the first chosen regenerative substance.

    摘要翻译： 一种再生系统，其具有包含第一选择再生物质的第一再生模块; 包含第一选择再生物质的第二再生模块; 和第一混合室。 流体的第一出口流顺序地离开第一混合室，流过第一再生模块与第一选择的再生物质流体连通并返回到第一混合室，并且流体的第二出口流依次离开第一混合 并且与第一选择的再生物质流体连通地流过第二再生模块。

    Multi-location posture sensing
    9.
    发明授权
    Multi-location posture sensing 有权
    多位置姿态检测

    公开(公告)号：US08788055B2

    公开(公告)日：2014-07-22

    申请号：US11800653

    申请日：2007-05-07

    申请人： Martin T. Gerber ,  John C. Rondoni

    发明人： Martin T. Gerber ,  John C. Rondoni

    IPC分类号： A61N1/36 ,  A61N1/05

    CPC分类号： A61N1/36135 ,  A61N1/0551 ,  A61N1/36514 ,  A61N1/36535 ,  A61N1/36542

    摘要： Techniques for controlling therapy delivery based on the relative orientation and/or motion of a device accelerometer and a lead accelerometer are described. In one embodiment, a therapy system includes an electrical stimulator and a lead. The electrical stimulator comprises a processor that controls delivery of a therapy to a target stimulation site in a patient and a device accelerometer coupled to the electrical stimulator. The lead is coupled to the electrical stimulator to deliver the therapy from the electrical stimulator to the target stimulation site in the patient, and includes a lead accelerometer. The processor compares signals from the accelerometers, and controls delivery of the therapy to the patient based on the comparison. In this manner, the processor may adjust stimulation to, for example, address movement of electrodes relative to target tissue when a patient changes postures.

    摘要翻译： 描述了基于设备加速度计和线加速度计的相对取向和/或运动来控制治疗递送的技术。 在一个实施例中，治疗系统包括电刺激器和引线。 电刺激器包括处理器，其控制对患者的目标刺激部位的治疗传递和耦合到电刺激器的装置加速度计。 引线耦合到电刺激器以将治疗从电刺激器传递到患者中的目标刺激部位，并且包括引线加速度计。 处理器比较来自加速度计的信号，并且基于比较来控制对患者的治疗传递。 以这种方式，当患者改变姿势时，处理器可以将刺激调整为例如电极相对于靶组织的地址移动。